4.6 Article

Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy

Kate Absolom et al.

Summary: The study evaluated the impact of eRAPID on symptom control, healthcare use, patient self-efficacy, and quality of life during cancer treatment. Results showed that patients using eRAPID had better physical well-being and higher self-efficacy.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Development and validation of the measure of ovarian symptoms and treatment concerns for surveillance (MOST-S26): An instrument to complement the clinical follow-up of women with ovarian cancer after completion of first-line treatment

Rachel Campbell et al.

Summary: The study developed and validated the MOST-S26 for surveillance of women in follow-up after first-line chemotherapy for OC. MOST-S26 reliably detected improvement in symptoms of peripheral neuropathy, psychological distress, and may detect symptoms of relapse. Administration of MOST-S26 in follow-up consultations could identify concerning symptoms and facilitate timely and appropriate intervention.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial

Charles Loprinzi et al.

SUPPORTIVE CARE IN CANCER (2020)

Review Obstetrics & Gynecology

Latest clinical evidence of maintenance therapy in ovarian cancer

Christine S. Walsh

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2020)

Article Biochemistry & Molecular Biology

The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities

Dixon H. Xu et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2020)

Article Oncology

Insomnia and its association with quality of life in women with ovarian cancer

Tanya L. Ross et al.

GYNECOLOGIC ONCOLOGY (2020)

Article Oncology

Impact of oxaliplatin-induced neuropathy: a patient perspective

Barbara K. Bennett et al.

SUPPORTIVE CARE IN CANCER (2012)

Article Oncology

The effect of sleep disturbance on quality of life in women with ovarian cancer

Samith Sandadi et al.

GYNECOLOGIC ONCOLOGY (2011)

Article Obstetrics & Gynecology

Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients

Anne E. Kayl et al.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2006)

Article Psychology, Clinical

Social support, anxiety and depression after chemotherapy for ovarian cancer: A prospective study

J Hipkins et al.

BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2004)

Article Psychology, Clinical

Normative data for the HADS from a large non-clinical sample

JR Crawford et al.

BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2001)